Timothy Wigand

Timothy Wigand practices at Staten Island University Hospital - North Campus in Staten Island, New York.

Timothy Wigand's NPI, 1104289263, was assigned on April 5, 2016. Timothy Wigand graduated from State University of New York Downstate Medical Center in 2016. Timothy Wigand holds New York license 298393.

Timothy Wigand's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 226-4502.

Timothy Wigand's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Timothy Wigand is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck.

Dmand AI tracks the electronic health record (EHR) system at each site where Timothy Wigand practices. Vendor and product names are available with a free account.

Hospitalist is Timothy Wigand's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Timothy Wigand is licensed in New York.

CMS data shows 560 Medicare services from Timothy Wigand across 6 procedure codes in 2024, for 262 Medicare patients. Medicare paid $48,399 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 262 Medicare patients who saw Timothy Wigand in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Timothy Wigand's median patient age at 77, with 48% women.

In 2024, Timothy Wigand wrote 43 Medicare Part D claims for 19 patients. 84% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $210 in total drug cost. In 2017, CMS named 45 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Timothy Wigand for performance year 2024, reported through an alternative payment model (APM). Timothy Wigand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Timothy Wigand as offering telehealth.

CMS Open Payments shows 1 general payment to Timothy Wigand from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Merz North America, Inc. paid the most, $142.

Timothy Wigand graduated from State University of New York Downstate Medical Center in 2016.